Valneva to Present and Hold Investor Meetings at Upcoming U.S. and European Healthcare Conferences

Valneva announced senior management will present and hold investor meetings at four U.S. and European healthcare conferences between October 15 and November 16, 2026. Fireside chats will focus on the regulatory outlook for its Pfizer-partnered Lyme disease vaccine candidate, with regulatory decisions expected within the next 12 months.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.